Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
2.025
-0.075 (-3.57%)
At close: Jun 9, 2026, 4:00 PM EDT
2.050
+0.025 (1.23%)
After-hours: Jun 9, 2026, 7:59 PM EDT
Indaptus Therapeutics Market Cap
Indaptus Therapeutics has a market cap or net worth of $229.32 million as of June 9, 2026. Its market cap has increased by 3,669.50% in one year.
Market Cap
229.32M
Enterprise Value
227.82M
1-Year Change
3,669.50%
Ranking
Category
Stock Price
$2.03
Market Cap Chart
Since August 4, 2021, Indaptus Therapeutics's market cap has increased from $47.95M to $229.32M, an increase of 378.23%. That is a compound annual growth rate of 38.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 237.81M | 4,566.69% |
| Dec 31, 2025 | 5.10M | -49.63% |
| Dec 31, 2024 | 10.12M | -31.58% |
| Dec 29, 2023 | 14.79M | 21.38% |
| Dec 30, 2022 | 12.18M | -73.92% |
| Dec 31, 2021 | 46.70M | -2.60% |
| Aug 4, 2021 | 47.95M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sutro Biopharma | 432.32M |
| Contineum Therapeutics | 429.57M |
| C4 Therapeutics | 424.20M |
| Neurogene | 418.59M |
| Sagimet Biosciences | 417.44M |
| Editas Medicine | 415.88M |
| Autolus Therapeutics | 407.20M |
| Forte Biosciences | 403.68M |